Invention Grant
- Patent Title: Targeted liposomal gemcitabine compositions and methods thereof
-
Application No.: US15587018Application Date: 2017-05-04
-
Publication No.: US10940112B2Publication Date: 2021-03-09
- Inventor: Clet Niyikiza , Victor Moyo , Zhenghong Xu , Kaniz Khalifa
- Applicant: L.E.A.F. Holdings Group LLC
- Applicant Address: US PA Gulph Mills
- Assignee: L.E.A.F. Holdings Group LLC
- Current Assignee: L.E.A.F. Holdings Group LLC
- Current Assignee Address: US PA Gulph Mills
- Agency: Nixon & Vanderhye, PC
- Main IPC: A61K9/127
- IPC: A61K9/127 ; C07K16/28 ; A61K45/06 ; A61K47/68 ; A61K47/69 ; A61K33/243 ; A61P31/18 ; A61K31/337 ; A61K31/555 ; A61K31/4745 ; A61P35/00 ; A61K31/7068 ; C07K16/30
Abstract:
This disclosure relates to a targeted PEGylated liposomal gemcitabine (PLG) composition comprising a PEGylated liposome encapsulating one or more agents comprising gemcitabine and a targeting moiety; pharmaceutical composition and methods comprising PLG or producing PLG; and manufacturing equipment for performing the methods.
Public/Granted literature
- US20170319482A1 TARGETED LIPOSOMAL GEMCITABINE COMPOSITIONS AND METHODS THEREOF Public/Granted day:2017-11-09
Information query
